{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:14:21Z","timestamp":1744200861585,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11695-022-06416-y","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:02:57Z","timestamp":1671519777000},"page":"548-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Value of Non-invasive Liver Function Tests in Liver Fibrosis and Changes in These Parameters Post-metabolic Surgery"],"prefix":"10.1007","volume":"33","author":[{"given":"Sara","family":"Jangjoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Emami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Sahranavard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb Z.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Alidadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Baratzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-2231","authenticated-orcid":false,"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jangjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"issue":"1","key":"6416_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-230X-10-40","volume":"10","author":"T Poynard","year":"2010","unstructured":"Poynard T, Lebray P, Ingiliz P, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterol. 2010;10(1):40. https:\/\/doi.org\/10.1186\/1471-230X-10-40.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"6416_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209\u201318.","journal-title":"J Clin Invest"},{"key":"6416_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"6416_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","volume":"12","author":"AF Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, Silva J\u00fanior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12(1):60. https:\/\/doi.org\/10.1186\/s13098-020-00570-y.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"6416_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatol. 2016;64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431.","journal-title":"Hepatol"},{"key":"6416_CR6","doi-asserted-by":"publisher","unstructured":"Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol.\u00a02015;39(39 Suppl 1(0 1)):S60\u20133.\u00a0https:\/\/doi.org\/10.1016\/j.clinre.2015.06.015.","DOI":"10.1016\/j.clinre.2015.06.015"},{"issue":"6","key":"6416_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1572-0241.2004.30110.x","volume":"99","author":"NH Afdhal","year":"2004","unstructured":"Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004;99(6):1160\u201374.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"6416_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jfma.2020.08.019","volume":"120","author":"G Gheorghe","year":"2021","unstructured":"Gheorghe G, Bung\u0103u S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc. 2021;120(2):794\u2013803. https:\/\/doi.org\/10.1016\/j.jfma.2020.08.019.","journal-title":"J Formos Med Assoc"},{"key":"6416_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijcard.2018.05.087","volume":"270","author":"TG Simon","year":"2018","unstructured":"Simon TG, Corey KE, Cannon CP, et al. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe. Int J Cardiol. 2018;270:245\u201352.","journal-title":"Int J Cardiol"},{"issue":"8","key":"6416_CR10","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s11695-019-03889-2","volume":"29","author":"T Jamialahmadi","year":"2019","unstructured":"Jamialahmadi T, Nematy M, Jangjoo A, et al. Measurement of liver stiffness with 2D-shear wave elastography (2D-SWE) in bariatric surgery candidates reveals acceptable diagnostic yield compared to liver biopsy. Obes Surg. 2019;29(8):2585\u201392. https:\/\/doi.org\/10.1007\/s11695-019-03889-2.","journal-title":"Obes Surg"},{"issue":"3","key":"6416_CR11","doi-asserted-by":"publisher","first-page":"e1549","DOI":"10.1590\/0102-672020200003e1549","volume":"33","author":"MB Goldoni","year":"2021","unstructured":"Goldoni MB, Fontes PRO, Guimar\u00c3es MM, et al. Bypass vs. sleeve and its effects in non-alcoholic fatty liver disease: what is the best technique? Arq Bras Cir Dig. 2021;33(3):e1549. https:\/\/doi.org\/10.1590\/0102-672020200003e1549.","journal-title":"Arq Bras Cir Dig"},{"issue":"11","key":"6416_CR12","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/jcm11113043","volume":"11","author":"AM Amzolini","year":"2022","unstructured":"Amzolini AM, For\u021bofoiu M-C, Alhija AB, et al. Triglyceride and glucose index as a screening tool for nonalcoholic liver disease in patients with metabolic syndrome. J Clin Med. 2022;11(11):3043.","journal-title":"J Clin Med"},{"issue":"8","key":"6416_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jgh3.12606","volume":"5","author":"MS Kuchay","year":"2021","unstructured":"Kuchay MS, Choudhary NS, Mishra SK, et al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. JGH Open. 2021;5(8):915\u201322.","journal-title":"JGH Open"},{"key":"6416_CR14","doi-asserted-by":"publisher","unstructured":"Liu T, Wang X, Karsdal MA, et al. Molecular serum markers of liver fibrosis. Biomark.\u00a02012;7:BMI.S10009. https:\/\/doi.org\/10.4137\/bmi.S10009.","DOI":"10.4137\/bmi.S10009"},{"issue":"6","key":"6416_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s00535-009-0046-6","volume":"44","author":"H Fujii","year":"2009","unstructured":"Fujii H, Enomoto M, Fukushima W, et al. Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis. J Gastroenterol. 2009;44(6):608\u201314.","journal-title":"J Gastroenterol"},{"issue":"6","key":"6416_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/hep.20717","volume":"41","author":"C Lackner","year":"2005","unstructured":"Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatol. 2005;41(6):1376\u201382.","journal-title":"Hepatol"},{"issue":"9","key":"6416_CR17","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1023\/A:1018888021118","volume":"43","author":"DW Reedy","year":"1998","unstructured":"Reedy DW, Loo AT, Levine RA. AST\/ALT ratio\u2265 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci. 1998;43(9):2156\u20139.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"6416_CR18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatol. 2007;45(4):846\u201354. https:\/\/doi.org\/10.1002\/hep.21496.","journal-title":"Hepatol"},{"issue":"4","key":"6416_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"J Llovet","year":"2012","unstructured":"Llovet J, Ducreux M, Lencioni R, et al. European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343.","journal-title":"J Hepatol"},{"issue":"1","key":"6416_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatol. 2018;67(1):328\u201357.","journal-title":"Hepatol"},{"issue":"6","key":"6416_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW-S, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919.","journal-title":"Hepatol Int"},{"issue":"5","key":"6416_CR22","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s11695-020-04996-1","volume":"31","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani SA, Golabi P, Paik JM, et al. Performance of noninvasive liver fibrosis tests in morbidly obese patients with nonalcoholic fatty liver disease. Obes Surg. 2021;31(5):2002\u201310.","journal-title":"Obes Surg"},{"issue":"1","key":"6416_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11695-016-2246-5","volume":"27","author":"GJ Ooi","year":"2017","unstructured":"Ooi GJ, Burton PR, Doyle L, et al. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese. Obes Surg. 2017;27(1):115\u201325.","journal-title":"Obes Surg"},{"issue":"10","key":"6416_CR24","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41366-021-00881-8","volume":"45","author":"A Drolz","year":"2021","unstructured":"Drolz A, Wolter S, Wehmeyer MH, et al. Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. Int J Obes. 2021;45(10):2197\u2013204.","journal-title":"Int J Obes."},{"issue":"5","key":"6416_CR25","doi-asserted-by":"publisher","first-page":"e2008","DOI":"10.1210\/clinem\/dgab933","volume":"107","author":"S Qadri","year":"2022","unstructured":"Qadri S, Ahlholm N, L\u00f8nsmann I, et al. Obesity modifies the performance of fibrosis biomarkers in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2022;107(5):e2008\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"6416_CR26","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/ajg.2012.314","volume":"107","author":"Y-M Kwon","year":"2012","unstructured":"Kwon Y-M, Oh S-W, Hwang S-s, et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12):1852\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"6416_CR27","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/ajg.2012.320","volume":"107","author":"MR Pagadala","year":"2012","unstructured":"Pagadala MR, McCullough AJ. Non-alcoholic fatty liver disease and obesity: not all about body mass index. Am J Gastroenterol. 2012;107(12):1859\u201361.","journal-title":"Am J Gastroenterol"},{"key":"6416_CR28","doi-asserted-by":"publisher","unstructured":"Jamialahmadi T, Alidadi M, Atkin SL, et al. Effect of bariatric surgery on flow-mediated vasodilation as a measure of endothelial function: a systematic review and meta-analysis. J Clin Med. 2022;11(14). https:\/\/doi.org\/10.3390\/jcm11144054.","DOI":"10.3390\/jcm11144054"},{"key":"6416_CR29","doi-asserted-by":"publisher","unstructured":"Jamialahmadi T, Reiner \u017d, Alidadi M, et al. The effect of bariatric surgery on circulating levels of lipoprotein (a): a meta-analysis. BioMed Res Int. 2022;2022. https:\/\/doi.org\/10.1155\/2022\/8435133.","DOI":"10.1155\/2022\/8435133"},{"key":"6416_CR30","doi-asserted-by":"publisher","unstructured":"Jamialahmadi T, Reiner \u017d, Alidadi M, et al. The effect of bariatric surgery on circulating levels of oxidized low-density lipoproteins is apparently independent of changes in body mass index: a systematic review and meta-analysis. Oxidative Medicine and Cellular Longevity. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/4136071.","DOI":"10.1155\/2021\/4136071"},{"issue":"10","key":"6416_CR31","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1007\/s11695-021-05611-7","volume":"31","author":"T Jamialahmadi","year":"2021","unstructured":"Jamialahmadi T, Reiner \u017d, Alidadi M, et al. Impact of bariatric surgery on pulse wave velocity as a measure of arterial stiffness: a systematic review and meta-analysis. Obes Surg. 2021;31(10):4461\u20139. https:\/\/doi.org\/10.1007\/s11695-021-05611-7.","journal-title":"Obes Surg"},{"issue":"5","key":"6416_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s11695-022-05976-3","volume":"32","author":"N Nabavi","year":"2022","unstructured":"Nabavi N, Ghodsi A, Rostami R, et al. Impact of bariatric surgery on carotid intima-media thickness in patients with morbid obesity: a prospective study and review of the literature. Obes Surg. 2022;32(5):1563\u20139. https:\/\/doi.org\/10.1007\/s11695-022-05976-3.","journal-title":"Obes Surg"},{"issue":"15","key":"6416_CR33","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCULATIONAHA.120.052386","volume":"143","author":"AG Doumouras","year":"2021","unstructured":"Doumouras AG, Wong JA, Paterson JM, et al. Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study. Circulation. 2021;143(15):1468\u201380. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052386.","journal-title":"Circulation"},{"issue":"5","key":"6416_CR34","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.5114\/aoms\/152685","volume":"18","author":"T Jamialahmadi","year":"2022","unstructured":"Jamialahmadi T, Banach M, Almahmeed W, et al. Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis. Arch Med Sci. 2022;18(5):1372\u20137. https:\/\/doi.org\/10.5114\/aoms\/152685.","journal-title":"Arch Med Sci"},{"key":"6416_CR35","doi-asserted-by":"publisher","unstructured":"Jamialahmadi T, Reiner \u017d, Alidadi M, et al. Effect of bariatric surgery on intima media thickness: a systematic review and meta-analysis. J Clin Med. 2022;11(20). https:\/\/doi.org\/10.3390\/jcm11206056.","DOI":"10.3390\/jcm11206056"},{"key":"6416_CR36","doi-asserted-by":"publisher","unstructured":"Jamialahmadi T, Abbasifard M, Reiner \u017d, Kesharwani P, Sahebkar A. The effect of bariatric surgery on circulating levels of monocyte chemoattractant protein-1: a systematic review and meta-analysis. J Clin Med. 2022;11:7021. https:\/\/doi.org\/10.3390\/jcm11237021.","DOI":"10.3390\/jcm11237021"},{"issue":"7","key":"6416_CR37","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s11695-011-0559-y","volume":"22","author":"M Moretto","year":"2012","unstructured":"Moretto M, Kupski C, da Silva VD, et al. Effect of bariatric surgery on liver fibrosis. Obes Surg. 2012;22(7):1044\u20139. https:\/\/doi.org\/10.1007\/s11695-011-0559-y.","journal-title":"Obes Surg"},{"key":"6416_CR38","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2021.021","author":"D Toman","year":"2021","unstructured":"Toman D, Vavra P, Jelinek P, et al. Effect of bariatric surgery on fatty liver disease in obese patients: a prospective one year follow-up study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021. https:\/\/doi.org\/10.5507\/bp.2021.021.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"6416_CR39","doi-asserted-by":"publisher","first-page":"839275","DOI":"10.1155\/2013\/839275","volume":"2013","author":"S Hafeez","year":"2013","unstructured":"Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes. 2013;2013:839275. https:\/\/doi.org\/10.1155\/2013\/839275.","journal-title":"J Obes"},{"key":"6416_CR40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1590\/2359-3997000000233","volume":"61","author":"RB Nones","year":"2017","unstructured":"Nones RB, Ivantes CP, Pedroso MLA. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist? Arch Endocrinol. 2017;61:276\u201381.","journal-title":"Arch Endocrinol"},{"issue":"3","key":"6416_CR41","first-page":"218","volume":"25","author":"V Papastergiou","year":"2012","unstructured":"Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012;25(3):218\u201331.","journal-title":"Ann Gastroenterol"},{"issue":"9","key":"6416_CR42","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","volume":"53","author":"T Poynard","year":"2007","unstructured":"Poynard T, Halfon P, Castera L, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem. 2007;53(9):1615\u201322.","journal-title":"Clin Chem"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06416-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T15:05:49Z","timestamp":1675177549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06416-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6416"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06416-y","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"type":"print","value":"0960-8923"},{"type":"electronic","value":"1708-0428"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"30 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval Statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}